Literature DB >> 21607598

Hemangiomas revisited: the useful, the unusual and the new. Part 2: endangering hemangiomas and treatment.

Ricardo Restrepo1, Rajaneeshankar Palani, Luisa F Cervantes, Ana-Margarita Duarte, Ibrahim Amjad, Nolan R Altman.   

Abstract

Hemangiomas, although benign tumors, can when located in particular regions threaten vital structures or in certain clinical circumstances be associated with other abnormalities, carrying significant morbidity and mortality. We review these endangering hemangiomas. We also discuss briefly the treatment with emphasis on the recent use of propranolol.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21607598     DOI： 10.1007/s00247-011-2090-7

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


  55 in total

1.  Cavernous haemangioma of the breast.

Authors:  S M Kim; H H Kim; H J Shin; G Gong; S-H Ahn
Journal:  Br J Radiol       Date:  2006-11       Impact factor: 3.039

2.  Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee.

Authors:  I J Frieden; L F Eichenfield; N B Esterly; R Geronemus; S B Mallory
Journal:  J Am Acad Dermatol       Date:  1997-10       Impact factor: 11.527

3.  Growing up with a facial hemangioma: parent and child coping and adaptation.

Authors:  J L Tanner; M P Dechert; I J Frieden
Journal:  Pediatrics       Date:  1998-03       Impact factor: 7.124

4.  SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization.

Authors:  Annelies Stockman; F Boralevi; Alain Taïeb; Christine Léauté-Labrèze
Journal:  Dermatology       Date:  2007       Impact factor: 5.366

5.  Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon.

Authors:  Alla Gruman; Marilyn G Liang; John B Mulliken; Steven J Fishman; Patricia E Burrows; Harry P W Kozakewich; Francine Blei; Ilona J Frieden
Journal:  J Am Acad Dermatol       Date:  2005-04       Impact factor: 11.527

Review 6.  Pediatric hepatic vascular anomalies.

Authors:  P E Burrows; J Dubois; A Kassarjian
Journal:  Pediatr Radiol       Date:  2001-08

7.  A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications.

Authors:  D W Metry; A N Haggstrom; B A Drolet; E Baselga; S Chamlin; M Garzon; K Horii; A Lucky; A J Mancini; B Newell; A Nopper; G Heyer; I J Frieden
Journal:  Am J Med Genet A       Date:  2006-05-01       Impact factor: 2.802

8.  Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin.

Authors:  Beth A Drolet; Sarah L Chamlin; Maria C Garzon; Denise Adams; Eulalia Baselga; Anita N Haggstrom; Kristen E Holland; Kimberly A Horii; Anna Juern; Anne W Lucky; Anthony J Mancini; Catherine McCuaig; Denise W Metry; Kimberly D Morel; Brandon D Newell; Amy J Nopper; Julie Powell; Ilona J Frieden
Journal:  J Pediatr       Date:  2010-09-09       Impact factor: 4.406

9.  Consensus Statement on Diagnostic Criteria for PHACE Syndrome.

Authors:  Denise Metry; Geoffrey Heyer; Christopher Hess; Maria Garzon; Anita Haggstrom; Peter Frommelt; Denise Adams; Dawn Siegel; Karla Hall; Julie Powell; Ilona Frieden; Beth Drolet
Journal:  Pediatrics       Date:  2009-10-26       Impact factor: 7.124

10.  Management of parotid hemangioma in 100 children.

Authors:  Arin K Greene; Gary F Rogers; John B Mulliken
Journal:  Plast Reconstr Surg       Date:  2004-01       Impact factor: 4.730
View more
  4 in total

1.  Radiographic findings associated with vascular anomalies.

Authors:  Prakash Masand
Journal:  Semin Plast Surg       Date:  2014-05       Impact factor: 2.314

Review 2.  Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy.

Authors:  Andreas Fette
Journal:  ScientificWorldJournal       Date:  2013-05-20

3.  A 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol.

Authors:  Aziz Eghbali; Shabnam Hajiani; Bahman Sadeghi Sedeh; Abdolghader Pakniyat; Vahid Mansouri; Bahador Bagheri
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

4.  Congenital hepatic haemangioma leading to multiple organ failure in a neonate.

Authors:  Sarah Aouni; Vinciane Vlieghe; Valérie Segers; Catherine Christophe
Journal:  BJR Case Rep       Date:  2016-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.